Understanding Fentanyl Citrate Injection Formulations in the UK: A Clinical Overview
Fentanyl citrate remains among the most important tools in modern-day anaesthesia and sharp pain management throughout the United Kingdom. As a potent synthetic opioid, its function in the National Health Service (NHS) and personal surgical sectors is reputable, primarily due to its rapid beginning of action and cardiovascular stability. This blog post offers a thorough summary of fentanyl citrate injection formulations readily available in the UK, their scientific indications, regulatory landscape, and administration protocols.
What is Fentanyl Citrate?
Fentanyl citrate is a potent phenylpiperidine-derivative opioid agonist. It was first manufactured in 1960 and quickly became a foundation of perioperative care. In regards to strength, fentanyl is around 50 to 100 times more powerful than morphine. Its high lipophilicity allows it to cross the blood-brain barrier quickly, leading to a nearly instant analgesic impact when administered intravenously.
In the UK, fentanyl citrate is primarily used by means of the parenteral path (injection) for both sedative and analgesic functions. It works primarily by binding to the mu-opioid receptors in the central nerve system, changing the understanding of pain and the emotional reaction to it.
Medical Indications in the UK
According to the British National Formulary (BNF), fentanyl citrate injection is indicated for a number of particular scientific circumstances:
- Analgesic Action: Used throughout short personnel procedures and in the healing room.
- Analgesic Supplement: Used throughout the induction and upkeep of inhalation anaesthesia.
- Neuroleptanalgesia: Often used in mix with a neuroleptic (such as droperidol) to accomplish a state of quiescence and minimized awareness.
- Management of Severe Pain: Particularly in the Intensive Care Unit (ICU) for clients on mechanical ventilation.
- Pre-medication: To offer sedation and analgesia before the induction of general anaesthesia.
Readily Available Formulations and Strengths in the UK
The UK market uses several formulations of fentanyl citrate, created to meet the varying needs of surgical and emergency departments. These are generally provided as clear, colourless services for injection or infusion.
Table 1: Common Fentanyl Citrate Formulations in the UK
| Strength (Fentanyl base) | Presentation | Common Packaging | Maker Examples |
|---|---|---|---|
| 50 micrograms/ml | 2 ml Ampoule | Pack of 10 | Hameln, Advanz Pharma |
| 50 micrograms/ml | 10 ml Ampoule | Load of 5 or 10 | Hameln, Wockhardt |
| 50 micrograms/ml | 20 ml Vial/Ampoule | Pack of 5 | Hameln, Generic |
| 50 micrograms/ml | 50 ml Vial | Individual/Pack of 1 | Generic (ICU use) |
Note: While 50 mcg/ml is the standard concentration, specialised formulations for epidural or intrathecal usage may in some cases be prepared by health center drug stores under particular procedures.
Pharmacokinetics and Pharmacodynamics
Understanding how the body processes fentanyl is essential for safe administration.
- Start of Action: When administered intravenously, the effect begins almost immediately, though the optimum analgesic result might take 3 to 5 minutes.
- Duration: A single intravenous dosage of 100 micrograms usually lasts for 30 to 60 minutes.
- Metabolism: Fentanyl is primarily metabolised in the liver via the CYP3A4 enzyme system.
- Excretion: Approximately 75% of the dose is excreted in the urine within 24 hours, mainly as metabolites.
Administration Protocols
In the UK, the administration of fentanyl citrate is strictly controlled and typically carried out by anaesthetists or trained practitioners in controlled environments.
Dose Guidelines
Dosage must be horizontal and individualised based on the patient's age, weight, physical status, underlying pathological condition, use of other drugs, and the type of surgery.
- Low Dose (2 mcg/kg): Useful for minor surgical treatments.
- Moderate Dose (2-- 20 mcg/kg): Used when surgery is more invasive; requires breathing monitoring.
- High Dose (20-- 50 mcg/kg): Used during "trouble-free" major surgeries (e.g., open-heart surgical treatment) to protect the myocardium from the metabolic demands of tension.
Paths of Administration
- Intravenous (IV) Bolus: Common for induction.
- Intravenous Infusion: Used for longer procedures or in the ICU.
- Intramuscular (IM): Less common, however utilized for pre-medication in specific situations.
Regulatory Status and Safety
In the United Kingdom, Fentanyl is classified under the Misuse of Drugs Act 1971 as a Class A drug. Under the Misuse of Drugs Regulations 2001, it is classified as a Schedule 2 Controlled Drug (CD POM).
Statutory Requirements for UK Hospitals:
- Safe Custody: Must be saved in a locked controlled drug cupboard.
- Record Keeping: Every administration should be taped in a Controlled Drugs Register (CDR).
- Destruction: Surplus or ended fentanyl must be denatured and experienced by authorised workers.
Side Effects and Adverse Reactions
While extremely efficient, fentanyl citrate carries a danger of considerable adverse effects.
- Respiratory Depression: The most serious side effect, which can lead to respiratory arrest if not kept track of.
- Bradychardia: Often managed with atropine.
- Muscle Rigidity (Chest Wall Rigidity): High doses can make ventilation difficult, needing the usage of neuromuscular obstructing agents.
- Queasiness and Vomiting: Common in the postoperative duration.
- Hypotension: Although more steady than morphine, it can still happen, particularly in hypovolaemic patients.
Contrast with Other Opioids
Clinicians frequently pick fentanyl over other opioids due to its particular pharmacokinetic profile.
Table 2: Comparison of Parenteral Opioids in UK Practice
| Function | Fentanyl | Morphine | Remifentanil |
|---|---|---|---|
| Relative Potency | 100 | 1 | 100-200 |
| Start | 1-- 3 minutes | 15-- 30 minutes | 1 minute |
| Period of Action | 30-- 60 minutes | 3-- 4 hours | 5-- 10 minutes |
| Histamine Release | Minimal | Considerable | Minimal |
| Primary Use | Intraoperative/ICU | Post-operative/Chronic | Titratable Infusion |
Regularly Asked Questions (FAQ)
1. Is fentanyl citrate injection the like the fentanyl patches?
No. While they contain the same active drug, the injection is for instant, intense usage in surgical or emergency situation settings. Patches (transdermal delivery) are created for chronic, long-term discomfort management and launch the medication slowly over 72 hours.
2. Can fentanyl citrate be used for kids in the UK?
Yes, it is frequently used in paediatric anaesthesia. Nevertheless, the dose needs to be strictly calculated based on the child's weight, and they should be kept track of carefully for respiratory anxiety.
3. What is the antagonist for fentanyl?
Naloxone is the specific pharmacological villain used to reverse the results of fentanyl, consisting of breathing depression. In UK medical facilities, naloxone should always be easily available wherever fentanyl is administered.
4. Why is it used over morphine in heart surgical treatment?
Fentanyl is chosen in cardiac surgery because it does not trigger the release of histamine, which can result in vasodilation and hypotension. It supplies cardiovascular stability even at high doses.
5. What are the storage requirements?
Fentanyl citrate injection must be saved listed below 25 ° C and secured from light. As a Schedule 2 drug, it must be kept in a legally compliant CD cabinet.
Fentanyl citrate injection formulas are vital parts of the UK's medical toolkit for managing perioperative pain and helping with intricate surgeries. Its high potency and fast start deal unrivaled accuracy for anaesthetists, provided that rigorous tracking and regulative requirements are kept. By comprehending the numerous concentrations and the rigorous protocols surrounding its usage, health care professionals make sure that this effective medication stays both safe and efficient for clients throughout the country.
Disclaimer: This short article is for informational purposes only and does not constitute medical recommendations. Fentanyl Citrate Injection Brand Names UK ought to always describe the Summary of Product Characteristics (SmPC) and current BNF guidelines for the most updated prescribing information.
